This article presents the average 12-month stock price targets for the 10 largest American cannabis multi-state operators (MSOs) - along with their percentage changes from today's price - according to the Wall Street analysts that cover these companies. In addition, the article provides the analyst consensus buy, hold and sell recommendations to help you with your investment decisions.

The above information is provided below in descending order of the expected percentage changes from today's stock price, as follows:

1. Ayr (AYRWF)
   • average price target is $3.07, a +210.20% increase from the March 7th price of $0.99
   • the highest analyst price target is $4.75, the lowest forecast is $1.38
   • consensus rating of Moderate Buy is based on 1 buy rating, 1 hold rating and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Columbia Care in the last 3 months
   • Source
2. ​​​​​​​Verano (VRNOF)
   • average price target is $9.83, a +193.43% increase from the March 7th price of $3.36
   • the highest analyst price target is $16.17, the lowest forecast is $3.31
   • consensus rating of Strong Hold is based on 3 buy ratings, 1 hold rating and 0 sell ratings of 4 Wall Street analyst offering 12 month price targets for Verano in the last 3 months
   • Source
3. Cresco Labs (CRLBF)
   • average price target is $5.19, a +159.50% increase from the March 7th price of $2.00
   • the highest analyst price target is $4.00, the lowest forecast is $1.75
   • consensus rating of Moderate Buy is based on 1 buy rating, 1 hold rating and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Cresco Labs in the last 3 months
   • Source
4. Ascend (AAWH)
   • average price target is $2.88, a +130.40% increase from the March 7th price of $1.26
   • the highest analyst price target is $4.00, the lowest forecast is $1.75
   • consensus rating of Moderate Buy is based on 1 buy rating, 1 hold rating and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Ascend in the last 3 months
   • Source
5. Trulieve (TCNNF)
   • average price target is $14.25, a +117.89% increase from the March 7th price of $6.54
   • the highest analyst price target is $14.25, the lowest forecast is $14.25
   • consensus rating of Moderate Buy is based on 1 buy rating, 0 hold ratings and 0 sell ratings of 1 Wall Street analyst offering 12 month price targets for Trulieve in the last 3 months
   • Source
6. Curaleaf (CURLF)
   • average price target is $7.42, a +92.73% increase from the March 7th price of $3.85
   • the highest analyst price target is $12.00, the lowest forecast is $5.00
   • consensus rating of Strong Buy is based on 4 buy ratings, 0 hold ratings and 0 sell ratings of 4 Wall Street analysts offering 12 month price targets for Curaleaf in the last 3 months
   • Source
7. Green Thumb (GTBIF)
   • average price target is $15.29, a +79.57% increase from the March 7th price of $8.52
   • the highest analyst price target is $23.52, the lowest forecast is $10.00
   • consensus rating of Strong Buy is based on 6 buy ratings, 1 hold ratings and 0 sell ratings of 7 Wall Street analysts offering 12 month price targets for Green Thumb in the last 3 months
   • Source
8. Columbia Care (CCHWF)
   • average price target is $1.15, a +72.93% increase from the March 7th price of $0.67
   • the highest analyst price target is $1.15, the lowest forecast is $1.15
   • consensus rating of Hold is based on 0 buy ratings, 2 hold ratings and 0 sell ratings of 2 Wall Street analyst offering 12 month price targets for Columbia Care in the last 3 months
   • Source
9. TerrAscend (TRSSF)
   • average price target is $2.05, a +20.27% increase from the March 7th price of $1.70
   • the highest analyst price target is $2.20, the lowest forecast is $1.75
   • consensus rating of Moderate Buy is based on 2 buy ratings, 1 hold rating and 0 sell ratings of 3 Wall Street analyst offering 12 month price targets for TerrAscend in the last 3 months
   • Source
10. Planet 13 (PLNHF)
    • average price target is $0.95, a +5.56% increase from the March 7th price of $3.85
    • the highest analyst price target is $0.95, the lowest forecast is $0.95
    • consensus rating of Hold is based on 0 buy ratings, 1 hold rating and 0 sell ratings of 1 Wall Street analyst offering 12 month price targets for Planet 13 in the last 3 months
    • Source

The average analyst price target for the above MSOs is +108.0% from today's price with 2 Strong Buy recommendations, 5 Moderate Buys, 1 Strong Hold and 2 Holds. That being said, the above 10 stocks currently are unchanged, on average, YTD, so they have a long way to go to achieve the analysts' forecasts.

More By This Author:

Wall Street Analysts Forecast 22% Increase In 5 Largest Canadian Cannabis LPs
Compass Pathways - Entering A Brave New World
GH Resources: Focus On Treatment-Resistant Depression Paying Off